Section K. Economic costs of ESRD. Vol 3 esrd. pg 731. K tables

Transcription

1 Section K Economic costs of ESRD Vol 3 esrd pg 731

2 Table K Total costs ($) of reported ESRD per calendar year all ESRD with at least one claim, & Table K Total costs ($) of reported ESRD : claim type & top ten DRG codes ESRD with at least one claim Table K costs ($) for ESRD : status & claim type model Table K Per person per year costs ($): ESRD with unknowns dropped (Model 1) model, & Table K. 738 Per person per year costs ($): dialysis with unknowns dropped (Model 1) model, & Table K Per person per year costs ($): hemodialysis with unknowns dropped (Model 1) model, & Table K Per person per year costs ($): CAPD/CCPD with unknowns dropped (Model 1) model, & Table K Per person per year costs ($): transplant with unknowns dropped (Model 1) model, & Table K Per person per year costs ($): dialysis (Model 2) & Table K Per person per year costs ($): with a transplant event within the year (Model 2) & Table K Per person per year costs ($): with a functioning graft (Model 2) & Table K Per person per year costs ($): with a graft failure within the year (Model 2) & Table K Physician/supplier costs per person per year ($): specialty model; only Table K Per person per year estimated costs ($): all non-esrd general ( percent sample), gender & race Table K Per person per year estimated costs ($): CKD general ( percent sample), & race Table K Per person per year estimated costs ($): with diabetes general ( percent sample) surviving entire year, & race Table K Per person per year estimated costs ($): with CVD general ( percent sample), & race Table K Per person per year estimated costs ($): without ESRD, CKD, diabetes, or CVD general ( percent sample), & race pg 732 The following symbols are used throughout this reference section CMS began collecting Hispanic ethnicity data in April 199; cells for years prior to 1996 have therefore been left blank. * Values for cells with ten or fewer are suppressed.. Zero values in this cell. Data for some early years are omitted from the printed tables; complete data are available on our website, at

3 Table K.1 K.1 Total costs ($) ($) of of reported ESRD per calendar year all all ESRD ESRD with with at at least least one one claim, claim, & ,74,870 7,638,04 13,114,076 16,32,631 1,40,94 14,62, ,36,178 9,10,248 10,316,618 11,46,326 12,331,87 13,730, ,76,2 16,646,421 24,161,28 28,66,467 26,94,666 2,81, ,086,281 47,061,118 8,137,41 64,68,391 70,482,674 64,439, ,336,611 33,987, ,783,72 40,633, ,370, ,237, ,674, ,62,73 1,147,773,28 1,216,6,784 1,23,049,327 1,270,494, ,17,299,470 1,94,12,087 2,271,830,361 2,438,834,010 2,0,471,642 2,49,4, ,464,323,89 2,178,392,69 3,412,600,967 3,732,723,416 4,003,348,044 4,1,062, ,362,333 1,271,188,044 1,970,843,842 2,128,173,186 2,232,184,9 2,336,488, ,321,921,027 1,669,36,914 2,471,87,286 2,647,462,136 2,727,89,89 2,784,96, ,134,749,084 3,128,141,429 4,416,696,972 4,682,44,397 4,772,470,29 4,833,1, ,304, ,300,940 1,176,63,727 1,27,066,292 1,323,86,14 1,32,428, ,137, ,722, ,614,32 77,93,88 849,377, ,24,24 Unknown 627, ,103 1,031, ,261 1,123, , ,944,882 80,8,841 10,729, ,249,814 12,309, ,610, ,694,870,3 1,97,07,480 2,38,261,109 2,724,663,824 2,811,692,868 2,84,60, ,016,126,47 4,33,288,16 6,689,71,071 7,242,266,8 7,69,731,392 7,92,267, ,77,089,108 3,373,436,917 4,813,118,9,132,217,118,24,323,26,378,261, ,484,022,441 2,478,08,177 3,928,343,61 4,248,710,92 4,418,701,378 4,06,70,226 Unknown 627, ,103 1,031, ,261 1,123, ,904 Male 4,4,40,119 6,232,78,016 9,429,69,747 10,283,13,100 10,747,288,836 11,077,716,08 Female 4,404,030,698,992,33,99 8,646,470,72 9,18,996,642 9,23,86,088 9,723,849,41 Unknown 110,22 13,663 1,614 86,426 7, ,878 White,239,822,479 6,960,823,273 10,291,62,166 11,093,177,48 11,03,332,112 11,827,928,776 African American 3,271,119,92 4,634,08,908 6,799,992,16 7,299,748,736 7,66,689,066 7,840,623,670 Native American 112,690, ,186,931 24,46,42 260,934,21 267,428, ,79,703 Asian 218,809, ,283,710 7,2, ,960,01 680,982,61 71,680,612 Other/unknown 17,239,222 92,92,82 163,339, ,41, ,40, ,69,743 Hispanic 1,406,039,363 2,310,119,639 2,3,41,0 2,682,928,822 2,810,161,32 Non-Hispanic 10,084,04,246 1,436,129,381 16,612,30,87 17,307,671,612 17,731,302,608 Unknown 73,239, ,807, ,433, ,282, ,224,366 Diabetes 3,34,66,323,236,43,792 8,141,249,34 8,847,62,643 9,277,81,4 9,40,236,82 Hypertension 2,624,889,494 3,319,43,409 4,868,887,377,21,743,781,396,42,174,42,713,966 Glomerulonephritis 1,266,690,28 1,21,078,241 1,977,264,30 2,066,219,416 2,093,337,379 2,086,18,131 Other cause 1,323,446,611 1,736,38,12 2,467,676,02 2,67,990,73 2,776,22,700 2,876,647,700 Unknown 299,088,63 411,980, ,978, ,719,73 726,781,863 7,71,884 All 8,89,681,339 12,22,332,673 18,076,06,086 19,469,236,168 20,270,882,671 20,801,688,0 Section K 4 Economic costs of ESRD 2009 USRDS Annual Data Report Includes all costs, beginning with the date of first ESRD service. hospital pass-through costs for indirect medical education, organ acquisition, etc. are included. Age is calculated as of January 1 of each calendar year. Vol 3 esrd pg 733

4 Table K.2 K.2 Total costs ($) of of reported ESRD : claim type & top ten DRG codes ESRD all ESRD with at least one with at least one claim claim Patients 267,1 344, , , ,128 44,281 Patient years at risk 223, ,720 32,894 36, , ,64 Total 8,92,44,499 12,337,43,971 18,270,182,300 19,704,214,390 20,22,841,816 21,07,667,74 Total inpatient ($) 3,481,702,88 4,74,188,396 6,66,648,744 7,09,764,464 7,188,272,34 7,347,304,777 Medical DRG 1,287,796,23 2,013,322,013 2,997,623,667 3,32,636,399 3,491,28,131 3,694,244,93 Surgical DRG 1,847,102,3 2,380,194,344 3,162,092,260 3,341,838,774 3,337,044,336 3,33,44,896 Other DRG 23,49,088 29,9,092 31,623,789 36,10,821 31,936,114 32,92,917 Transplant DRG 188,826, ,461, ,90,323 22,10,962 26,086,223 2,703,60 Non-tx pass-throughs 12,30, ,116, ,170, ,081,620 60,071,874 28,466,070 Tx pass-throughs 8,898,078,34,973,48,703 4,4,888 2,60, ,697 Total outpatient ($) 3,194,14,288 4,697,848,04 7,00,031,826 7,391,420,89 7,829,628,829 8,017,86,989 Outpatient HD 1,768,483,866 2,462,791,027 3,200,92,73 3,47,181,29 3,68,693,31 3,818,963,224 Outpatient PD 242,98, ,63, ,904, ,087, ,997, ,76,6 Outpatient other dial. 244, ,07 1,862,862 2,433,414 2,473,302 3,046,21 Outpatient ESA 67,243,140 1,082,82,213 1,827,48,438 1,868,397,663 1,882,497,283 1,840,760,373 Outpatient vitamin D 92,287,91 23,81, ,02,17 381,641,966 41,7, ,906,932 Outpatient iron 0,68, ,897, ,48, ,300, ,982, 2,08,946 Outpatient oth. inject. 19,21,99 80,494,489 81,732,74 82,28,038 86,870,31 81,267,166 Radiology,949,798 72,14,016 19,164, ,31, ,76,14 200,906,929 Pharmacy 60,772,830 60,41,316 9,428,918 9,901,263 6,416,33 8,34,913 Ambulance 4,662,96 7,08,391 17,73,97 20,321,648 20,203,807 22,04,41 Laboratory/pathology 101,12, ,68,888 13,89,139 16,199,02 170,822, ,219,649 Outpatient other 230,479, ,608, ,637, ,34, ,11, ,79,00 Skilled nursing facility 160,46, ,92,067 2,334,33 620,078, ,246, ,097,403 Home health agency 287,304, ,74,34 371,407, ,931, ,881, ,736,298 Hospice 8,0,078 19,709,043 6,869,748 68,31,080 70,69,0 81,072,990 Total physician/supplier ($) 1,793,340,948 2,34,190,878 3,672,890,39 4,101,668,617 4,293,244,384 4,38,90,117 Transplant surgery 20,29,012 17,64,630 20,344,369 21,738,637 21,926,391 22,783,384 Inpatient surgery 129,990,06 128,714,391 14,231,741 19,711,243 14,672,74 148,619,717 Outpatient surgery 79,403,116 99,12, ,37, ,209, ,71, ,467,492 ~E&M neph. inpatient 6,976,474 87,189,32 123,626,33 131,63, ,426, ,392,897 ~E&M neph. outpatient 10,93,940 13,7,144 21,129,064 22,276,903 22,163,706 24,290,766 ~E&M non-neph. inpatient 14,6, ,461,847 39,069,42 437,284, ,902, ,267,047 ~E&M non-neph. outpatient 63,190,317 11,204,91 189,998,442 20,446, ,99, ,730,147 Dialysis capitation 21,63, ,126,734 92,066, ,776,90 63,91,800 9,321,771 Inpatient dialysis 11,208,663 93,962, ,210,28 101,88,944 97,611,07 86,394,98 Home dialysis 123,442,30 13,67,004 2,8,466 46,76,914 26,76,028,468,483 Vascular access 142,217, ,927, ,920, ,027, ,81, ,182,699 Peritoneal access 4,969,362 3,92,28 3,62,488 3,80,93 3,419,769 2,87,98 Physician/supplier ESA 1,94,138 4,807,673 20,898,378 19,06,840 18,830,998 17,47,476 Physician/supplier iron 87,249 43,22 163, ,07 172,616 20,38 Immunosuppressive drugs 23,366,293 7,263, ,873,00 234,480, ,067, ,483,008 Durable medical equipment 68,97,67 82,18, ,269, ,787, ,203, ,626,120 Physician/supplier radiology 47,447,303 69,812, ,802, ,627,074 18,97, ,83,94 Physician/supplier lab/path. 192,931,79 182,881, ,66,282 34,84,921 36,6, ,628,418 Physician/supplier ambulance 179,414, ,312, ,7,812 60,288, ,72, ,38,794 Other physician/supplier 126,980,67 182,700, ,206,21 434,198,868 40,624,10 444,037,464 pg 734 ESA: erythropoiesis stimulating agent. ~E & M: evaluation & management. Includes all costs, beginning with the date of first ESRD service. hospital pass-through costs for indirect medical education, organ acquisition, etc. are included.

5 Table K.2 K.2 (continued) Total costs ($) ($) of of reported ESRD : claim type & top ten DRG codes ESRD all ESRD with at least one with at least one claim claim Top ten DRGs (rank order): ESRD ,708,92 184,11,11 220,32, ,240, ,641,60 278,762, ,7, ,9, ,828, ,130, ,037,999 22,748,72 242,683, ,330, ,799, ,92,89 288,174,68 296,733, ,660,22 270,879, ,77,037 1,023, ,77, ,929, ,821, ,129,920 2,300,83 22,91, ,043, ,130, ,223,89 24,86, ,970, ,467, ,626,08 262,00,17 24,183, ,670, ,099, ,338, ,343, ,764,07 201,23, ,207,64 230,989, ,192,063 23,983, ,613,70 10,44, ,004,69 137,743,131 17,40, ,928, ,10, ,388, ,161, ,932, ,00, ,814,4 20,322,00 211,248, ,34, ,391, ,69, ,33,42 Top ten DRGs (rank order): All dialysis ,31, ,106,114 21,391,26 237,822,11 244,072, ,49,78 30,223, ,937, ,469, ,493,40 188,601, ,113, ,446,20 230,027,30 247,997, ,360, ,000, ,133, ,840, ,807, ,27,770 18,264, ,72, ,499, ,340, ,093,363 23,662, ,97, ,984, ,980,18 22,327, ,211, ,93,024 26,88,38 266,980,97 27,694, ,830, ,467, ,832,87 96,34,38 102,607,883 12,14, ,219, ,669,347 11,10, ,19, ,929, ,94,800 19,628, ,827, ,972,27 177,786, ,274, ,196, ,91,209 17,743, ,337,43 204,763,89 147,901,467 Top ten DRGs (rank order): Hemodialysis ,343,8 170,962,300 20,340, ,816,32 233,999, ,97,20 293,919, ,17,42 322,749, ,033, ,446, ,44, ,360, ,866, ,60, ,62, ,89,69 21,029, ,719, ,26,338 17,398,12 17,468, ,6, ,74, ,994,96 229,333, ,072, ,124, ,606, ,483,81 21,291,26 231,62, ,400, ,620,832 27,433, ,312, ,842, ,03, ,920,279 86,737,20 92,838, ,608, ,723, ,132, ,292,844 17,18, ,823, ,82,64 182,79, ,923, ,419,10 171,091, ,214,632 19,061,03 162,293, ,701,42 4 2,07, ,040, ,070,178 Top ten DRGs (rank order): All diabetic ,082,991 76,331,368 93,666, ,16,30 109,433, ,372, ,7,241 14,01,014 10,904, ,09, ,38, ,486,242 7,282,87 60,692,488 74,464,913 8,962,36 87,227,262 92,434, ,28, ,7, ,43,81 66,999,141 78,006,702 8,39,26 9,848, ,0,680 11,324,91 114,633, ,306, ,71, ,601, ,04,949 69,01,42 79,8,26 8,98,444 87,69,318 97,924, ,437, ,179, ,121, ,32, ,92, ,676, ,08, ,24, ,622, ,698, ,3, ,384, ,394,329 99,269, ,, ,00, ,14, ,98, ,104,94 104,322, ,790, ,79, ,378,877 91,94, ,033, ,206,204 79,171,4 Top ten DRGs (rank order): All non - diabetic 144 4,62, ,179, ,68,20 138,724, ,208,486 16,390,009 17,999,98 183,44, ,924, ,084, ,986,74 146,190,460 16,697,888 1,671,61 164,87, ,14, ,99, ,611, ,697,07 133,397, ,908,28 149,344, ,178, ,17, ,881, ,30,88 172,224, ,339,186 88,024,339 98,70, ,33, ,973,632 13,624, ,97, ,281,488 14,737, ,600, ,340, ,33,624 14,680,9 128,478, ,92, ,778,278 12,298,11 132,189, ,911,39 140,213, ,003, ,31,20 130,647, ,28, ,817,796 88,029,864 92,032, ,206, ,166, ,31,889 97,068, ,84, ,08, ,9, ,280,393 89,740, ,343,34 10,84,977 7,404,921 Section K 4 Economic costs of ESRD 2009 USRDS Annual Data Report DRG Key: 113, Surgical, amputation for circulatory system disorders except upper-limb and toe; 120, Surgical, other circulatory system O.R. procedures; 127, Medical, Heart failure & shock; 144, Medical, other circulatory system diagnoses with complicating conditions; 302, Surgical, kidney transplant; 31, Surgical, other kidney and urinary tract O.R. procedures; 316, Medical, renal failure; 41, Surgical, O.R. procedures for infectious and parasitic diseases; 416, Medical, septicemia age >17; 462, Medical, rehabilitation; 41, Surgical, ECMO or tracheostomy with mechanical ventilation for 96+ hours, or principal except face, mouth, & neck with major O.R. procedure; 3, Surgical, other vascular procedures with complicating conditions with major cardiovascular ; 4, Surgical, other vascular procedures with complicating conditions without major cardiovascular. DRGs are ranked in order of total payments for calendar year 2006; 76, Medical, Septicemia without mechanical ventilation for 96+ hours with complicating conditions; 78, Surgical, Infectious and parasitic diseases with O.R. procedure, with complicating conditions. Vol 3 esrd pg 73

6 Table K.3 K.3 costs ($) for ESRD : status & claim type model model All secondary All secondary Patients 812,90 706, ,104 94,972 82, ,736 Patient years at risk 1,437,102 1,292, ,409 1,7,36 1,81, ,22 Total 62,432,224,284 61,71,092,3 681,131,731 93,179,61,230 92,179,9,61 999,69,79 Total inpatient ($) 23,894,399,119 23,493,739, ,69,417 33,0,947,216 32,29,283,669 26,663,47 Medical DRG 10,174,868,683 10,016,44,606 18,414,077 1,62,27,917 1,416,12, ,10,089 Surgical DRG 11,931,12,08 11,74,183,92 176,968,133 1,,177,682 1,320,7,46 234,422,136 Other DRG 141,468, ,319,230 2,149,237 16,671,870 13,91,136 2,720,734 Transplant DRG 936,128,83 887,637,73 48,490,848 1,202,348,13 1,19,068,743 43,279,392 Non-tx pass-throughs 681,96, ,499,610 13,097, ,642, ,241,86 9,400,901 Tx pass-throughs 29,184,481 27,644,69 1,39,912 19,848,846 19,113,1 73,29 Total outpatient ($) 23,838,311,681 23,783,27,177,04,04 3,763,04,268 3,668,831,232 94,673,036 Outpatient HD 12,449,060,36 12,443,640,626,419,910 18,002,916,692 17,991,4,444 11,461,247 Outpatient PD 801,233, ,148,73 1,08,24 1,331,733,783 1,330,342,142 1,391,641 Outpatient other dial. 3,077, 3,067,47 10,008 12,88,114 12,83,83 31,260 Outpatient ESA,422,72,922,419,627,998 2,944,924 8,03,321,677 8,046,618,72 6,702,92 Outpatient vitamin D 1,212,917,002 1,212,26, ,038 1,782,233,282 1,780,907,464 1,32,818 Outpatient iron 830,324, ,98,11 339,292 1,140,124,12 1,139,21, ,336 Outpatient oth. inject. 338,421,08 33,914,763 2,06,74 348,196, ,98,328 4,98,470 Radiology 387,389, ,101,06,288,29 792,169,10 783,63,037 8,34,472 Pharmacy 332,496,28 329,108,67 3,387,871 17,422,020 1,87,197 1,834,823 Ambulance 38,947,619 38,16, ,196 93,248,69 92,129,916 1,118,779 Laboratory/pathology 486,269,7 473,18,41 12,71, ,867, ,28,923 16,338,386 Outpatient other 1,3,99,827 1,1,100,194 20,499,633 3,430,38,26 3,389,922,414 40,462,81 Skilled nursing facility 1,60,216,291 1,89,249,790 1,966,01 2,903,728,970 2,872,88,489 31,140,481 Home health agency 1,077,734,064 1,066,2,906 11,478,18 1,984,812,490 1,964,6,99 20,246,30 Hospice 87,1,83 8,670,01 1,84,784 26,190, ,841,911 3,348,869 Total physician/supplier ($) 11,929,047,293 11,732,919, ,127,367 19,206,467,06 18,882,844, ,623,116 Transplant surgery 89,88,872 83,860,364,728,08 104,72,932 99,982,708 4,743,224 Inpatient surgery 631,449,20 618,80,286 12,643, ,686, ,73,407 14,933,284 Outpatient surgery 491,224, ,029,180 13,19,44 862,380,77 842,241,741 20,139,034 ~E&M neph. inpatient 433,617, ,726,244 6,891, ,33, ,98,782 10,349,899 ~E&M neph. outpatient 6,419,379 60,988,844 4,430,3 102,747,119 9,86,687 6,881,433 ~E&M non-neph. inpatient 1,213,93,34 1,194,892,448 19,042,897 2,00,007,20 2,017,980,88 32,026,931 ~E&M non-neph. outpatient 62,994,244 47,938,416 1,0, ,29, ,624,18 24,63,810 Dialysis capitation 2,126,284,73 2,109,198,334 17,086,239 2,922,001,086 2,899,761,919 22,239,168 Inpatient dialysis 490,287, ,098,339 4,188, ,847, ,160,940 4,686,178 Home dialysis 63,649, ,12,241 1,497, ,913, ,880,704 1,032,399 Vascular access 871,828,30 862,063,378 9,764,927 1,30,602,496 1,336,079,60 14,22,847 Peritoneal access 18,077,931 17,37,428 40,03 16,606,944 16,149,100 47,844 Physician/supplier ESA 20,224,007 19,236,12 987,8 74,743,283 70,684,239 4,09,044 Physician/supplier iron 267,76 2,123 12,43 68,94 646,020 39,934 Immunosuppressive drugs 428,44,27 398,01,036 30,043,491 1,106,043,3 1,038,636,49 67,407,040 Durable medical equipment 43,622,004 44,700,39 7,921,46 626,739, ,838,432 6,901,249 Physician/supplier radiology 36,43, ,362,711 8,090,68 672,42,701 69,013,064 13,29,637 Physician/supplier lab/path. 96,888, ,04,010 9,843,783 1,670,183,44 1,6,39,349 14,824,096 Physician/supplier ambulance 1,124,764,676 1,116,820,040 7,944,636 2,736,789,90 2,716,003,73 20,786,171 Other physician/supplier 97,92, ,708,812 21,216,470 1,914,624,67 1,87,196,673 39,427,894 pg 736 ESA: erythropoiesis stimulating agent. ~E & M: evaluation & management. The payment values include pro-rated costs, starting on the date of entitlement, as determined the USRDS sequence. Patients are at risk until death, loss of entitlement, or the end of the. Dialysis modality change or transplant results in a new modality.

7 Table K.4 K.4 Per person per year costs ($): ESRD all ESRD with with unknowns unknowns dropped dropped (Model (model 1) 1) model, model, & ,038 43,63 42,498 38,319 40,847 38,141 39,083 44,991 49,792,136 6,746 8,672 6, ,492 26,077 26,280 2,097 20,728 21,678 2,820 26,036 30,227 31,07 36,082 44,299 1, ,382 2,46 2,81 2,014 21,392 21,680 23,74 27,448 31,8 3,74 43,192 41,799 43, ,892 28,30 27,334 29,021 27,42 28,793 31,722 34,42 3,829 38,912 42,37 4,408 42, ,973 33,12 32,639 32,97 33,432 33,722 36,07 38,071 39,802 42,683 4,103 48,306 48, ,81 34,848 34,846 34,197 34,81 3,87 38,206 40,174 41,238 44,021 46,891 48,949 49, ,038 37,866 37,813 37,292 37,941 39,199 41,869 44,089 4,438 48,823 1,24 2,4 2, ,40 43,042 43,38 42,460 42,770 44,161 46,903 48,993 0,48 3,11,380 6,98 7, ,07 46,640 46,72 46,10 46,94 47,816 1,01 3,478,113 7,868 9,621 60,767 60, ,76 2,68 3,37 2,01 1,779 3,124,793 8,620 60,241 62,621 64,320 64,738 64, ,160 6,617 7,61 6,420 6,01 7,900 61,178 63,283 64,7 67,324 69,744 71,077 71, ,081 8,97 60,474 8,730 7,988 9,369 63,238 6,84 67,71 69,987 73,932 76,382 77,66 8+,691 9,9 60,467 8,926 8,840 60,089 63,407 6,641 69,029 70,338 74,664 77,842 79, ,133 28,92 27,990 28,108 2,779 26,6 29,300 32,341 3,13 38,617 43,998 4,738 44, ,908 3,172 3,094 34,633 3,226 36,063 38,62 40,819 42,013 44,937 47,960 49,89 0, ,600 43,028 43,171 42,60 42,92 44,32 47,12 49,32 0,882 3,990,79 7,22 7, ,016 4,068,00 3,976 3,389,069 7,90 60,199 61,739 63,994 66,01 66,670 66, ,681 8,412 9,28 8,109 7,722 9,191 62,840 6,349 67,237 69,794 73,06 7,326 76,064 Male 40,700 43,028 43,39 43,222 43,48 44,817 47,817 0,206 2,012 4,88 7,70 9,03 9,203 Female 46,233 49,027 49,93 48,839 48,962 0,48 3,80 6,371 7,872 60,861 62,928 64,11 64,9 White 41,983 44,293 44,96 44,44 44,24 4,662 48,67 0,989 2,706,47 7,897 9,312 9,64 African American 46,097 48,98 49,222 48,98 49,39 0,87 4,36 7,027 8,82 62,01 64,610 66,472 66,689 Native American 41,083 43,672 43,46 42,926 44,273 44,493 46,641 0,118 0,689 3,218 4,194,080,421 Asian 37,004 39,873 40,768 40,16 41,16 42,717 44,88 47,617 47,73 49,919 1,613 2,612 2,68 Other/unknown 3,102 4,494 2,062 2,718 2,688 6,69 7,90 9,091 8,670 61,68 62,27 60,609 9,6 Hispanic 4,44 46,14 4,928 4,676 47,029 49,823 2,30 4,12 6,802 9,068 60,786 61,204 Non-Hispanic 44,706 4,771 4,644 46,110 47,802 1,1 3,644,33 8,194 60,604 62,087 62,308 Diabetes 0,64 4,16 4,706 3,837 3,440,2 8,814 61,273 62,916 66,19 68,938 70,6 70,848 Hypertension 44,9 46,666 47,12 46,339 46,982 48,130 1,366 3,86,633 8,08 60,378 61,893 62,27 Glomerulonephritis 34,314 3,87 3,11 3,181 3,334 3,979 37,894 39,724 40,779 42,933 44,299 4,210 44,880 Other cause 37,42 39,8 39,939 39,460 39,698 41,072 43,660 4,849 47,0 49,944 2,076 3,202 3,786 Unknown cause 39,194 41,30 41,880 41,729 41,724 43,106 44,73 47,444 47,368 1,802 4,403 6,118,92 All 43,288 4,826 46,36 4,833 46,030 47,46 0,7 3,031 4,687 7,83 9,988 61,0 61,768 Section K 4 Economic costs of ESRD 2009 USRDS Annual Data Report Model 1: As-treated actuarial model, the standard USRDS economic model in which all costs are attributed to the patient s modality at the time the costs are incurred. In the case of a modality change, the costs incurred after the change are attributed to the new modality. See Appendix A (Volume Two) for further details. Age is calculated as of January 1 of each calendar year. Vol 3 esrd pg 737

8 Table K. K. Per person per year costs ($): dialysis with unknowns dropped (Model (model 1) 1) model, model, & ,003 6,119 9,817 1,279 3,173 4,1,287 8,877 6,390 80,081 86,643 78,482 76, ,146 48,200 3,037 1,370 4,411 49,10 49,796 47,402 48,281 2,162 6,849 73,802 69, ,61 44,074 42,89 44,064 38,99 41,074 43,00 4,220 49,007 48,212,919 60,73 61, ,082 41,12 39,660 42,697 40,021 43,801 46,40 0,31 49,09 49,843 7,124 60,310 7, ,341 43,732 42,14 42,489 43,939 44,43 46,64 48,796 1,064 3,649 6,139 60,16 61, ,187 46,298 46,447 4,76 46,999 48,062 0,691 2,73 4,146 6,381 9,888 62,767 63, ,679 47,212 46,994 46,90 48,277 49,860 2,802,2 7,373 60,614 63,419 6,283 6, ,87 0,39 0,760 0,274 1,426 2,920 6,160 8,97 60,31 63,69 6,92 68,01 68, ,771 2,072 2,418 2,633 3,3 4,761 8,632 61,787 63,494 66,972 68,966 70,29 70, ,283 6,881 7,97 7,248 6,908 8,642 61,927 6,321 67,730 70,680 73,174 74,8 7, ,296 8,064 9,243 8,131 7,98 60,12 63,686 66,226 68,216 71,397 74,42 76,727 77, ,216 8,72 60,67 8,961 8,284 9,734 63,679 66,410 68,391 70,714 74,843 77,64 79,201 8+,733 9,682 60,60 9,013 8,966 60,21 63,2 6,791 69,243 70,04 74,929 78,126 79, ,917 44,012 43,07 44,266 41,096 44,442 46,648 49,603 0,28 2,193 9,236 63,10 60, ,809 46,021 4,729 4,433 46,62 47,693 0,470 2,917 4,1 7,142 60,99 63,48 64, ,977 0,27 0,30 0,320 1,42 2,980 6,289 8,9 60,83 64,099 66,318 68,146 68, ,636 7,236 8,473 7,83 7,3 9,426 62,816 6,678 67,942 70,848 73,661 7,366 76, ,993 8,84 60,049 8,69 8,346 9,97 63,663 66,332 68,470 71,22 74,791 77,43 78,728 Male 47,49 0,623 1,204 0,904 1,14 3,013 6,197 8,931 61,08 63,970 67,211 69,314 69,916 Female 1,893,33 6,072,399,844 7,69 61,31 64,1 66,091 69,113 71,81 73,780 74,604 White 0,270 3,44 4,490 3,991 4,123,817 9,128 61,743 63,974 66,634 69,67 71,786 72,73 African American 49,248 2,600 2,892 2,391 3,426,002 8,747 61,648 63,710 67,174 69,980 72,260 72,827 Native American 4,23 48,839 48,366 48,014 49,309 49,813 2,087 6,132 6, 9,019 9,747 60,941 61,7 Asian 43,238 46,7 47,643 47,60 48,821 0,840 2,68,81 6,003 8,1 60,487 62,041 62,283 Other/unknown 6,37 6,071 2,847 3,49 3,708 7,661 8,966 60,34 9,20 62,761 6,64 66,288 68,878 Hispanic 2,328 2,780 2,709 2,812 4,273 7,272 60,470 62,378 64,907 67,24 69,769 70,798 Non-Hispanic 2,649 3,301 2,82 3,433,220 8,809 61,44 63,628 66,618 69,2 71,633 72,21 Diabetes,238 9,31 9,799 8,900 8,662 60,421 64,139 66,603 68,486 71,9 7,003 77,241 77,78 Hypertension 48,190 0,894 1,67 0,860 1,72 3,004 6,301 9,046 61,080 63,494 66,139 68,20 69,043 Glomerulonephritis 43,234 4,364 4,183 4,242 46,109 47,21 49,723 2,343 4,001 6,271 8,340 60,07 60,434 Other cause 46,660 49,706 0,772 0,294 1,322 3,363 6,76 9,16 61,974 64,310 67,189 68,790 69,784 Unknown cause 48,1 1,094 0,870 0,818 1,04 2,906 4,989 8,463 9,401 63,779 67,167 69,777 70,27 All 49,618 2,918 3,6 3,070 3,99,22 8,649 61,397 63,424 66,372 69,239 71,376 72,064 pg 738 Model 1: As-treated actuarial model, the standard USRDS economic model in which all costs are attributed to the patient s modality at the time the costs are incurred. In the case of a modality change, the costs incurred after the change are attributed to the new modality. See Appendix A (Volume Two) for further details. Age is calculated as of January 1 of each calendar year.

9 Table K.6 K.6 Per person per year costs ($): hemodialysis with unknowns dropped (Model (model 1) 1) model, model, & ,273 69,731 81,220 7,940 89,084 84,872 9,47 78,116 6,098 91, , ,176 92, ,490 8,423 63,24 7,684 7,444 0,198 61,207 9,44 64,664 66,114 69,1 93,160 67, ,763 48,862 46,078 3,01 43,667 4,8 1,48 3,987 4,989 1,327 8,96 60,4 69, ,661 43,36 41,16 4,019 41,178 4,849 48,87 3,104 1,671 3,438 9,670 63,786 60, ,19 4,318 44,243 43,62 4,121 4,628 48,219 0,13 2,880,62 7,863 61,942 63, ,694 47,888 47,748 46,776 48,362 49,186 2,146 4,308,840 8,204 61,46 64,47 6, ,818 48,434 48,063 47,98 49,370 0,893 3,922 6,8 8,84 62,074 6,004 66,727 67, ,700 1,173 1,721 0,881 2,231 3,608 6,993 9,49 61,77 64,667 67,090 69,101 69, ,83 2,890 3,126 3,107 3,969,200 9,249 62,480 64,383 68,011 69,902 71,483 72, ,870 7,71 8,491 7,66 7,328 9,147 62,228 6,844 68,363 71,393 73,928 7,221 7, ,692 8,409 9,420 8,201 8,032 60,109 63,690 66,431 68,477 71,844 74,821 77,16 78, ,234 8,740 60,69 8,694 7,848 9,34 63,266 6,99 67,966 70,397 74,38 77,277 78,960 8+,439 9,64 9,960 8,476 8,389 9,17 62,81 6,000 68,410 69,804 74,364 77,624 78, ,90 46,19 44,382 47,416 43,69 47,03 1,114 4,331 3,182 4,641 61,819 6,83 63, ,161 47,1 47,077 46,21 47,891 48,846 1,81 4,414 6,179 8,939 62,321 6,097 6, ,892 1,17 1,448 1,009 2,273 3,669 7,147 9,822 61,884 6,248 67,486 69,279 69, ,19 7,920 8,861 7,887 7,688 9,72 63,07 66,142 68,483 71,49 74,332 7,964 77,079 7+,084 8,888 9,984 8,42 8,026 9,64 63,32 66,060 68,226 71,084 74,679 77,491 78,62 Male 48,224 1,428 1,879 1,33 2,001 3,446 6,678 9,472 61,737 64,719 67,927 70,01 70,77 Female 3,041 6,613 7,207 6,309 6,748 8,02 62,20 6,19 67,141 70,3 72,822 74,920 7,906 White 1,2 4,93,622 4,861 4,937 6,40 9,917 62,621 64,990 67,714 70,73 72,807 73,66 African American 49,82 3,19 3,496 2,800 3,912,419 9,212 62,162 64,28 67,940 70,680 72,92 73,13 Native American 4,847 49,613 49,089 48, 49,860 0,273 2,96 6,863 7,042 9,664 60,276 61,380 62,213 Asian 44,491 48,116 48,98 48,610 49,747 1,911 3,744 7,003 7,223 9,469 62,068 63,66 63,614 Other/unknown 8,101 8,792,009,311,22 8,872 60,492 61,801 60,39 63,91 66,880 67,8 70,216 Hispanic 3,60 3,894 3,724 3,694,218 8,176 61,441 63,432 6,942 68,667 70,823 71,863 Non-Hispanic 3,71 4,220 3,490 4,069,769 9,429 62,26 64,442 67,93 70,4 72,36 73,184 Diabetes,944 60,101 60,384 9,319 9,092 60,743 64,04 67,042 69,04 72,86 7,621 77,802 78,363 Hypertension 48,837 1,634 2,08 1,222 2,093 3,377 6,672 9,64 61,614 64,218 66,864 68,974 69,810 Glomerulonephritis 44,763 46,922 46,62 46,382 47,270 48,40 1,040 3,77,479 8,049 60,061 61,70 62,146 Other cause 47,72 0,81 2,038 1,16 2,390 4,160 7,619 60,83 63,187 6,662 68,43 70,031 70,91 Unknown cause 49,286 2,337 1,947 1,18 1,492 3,440,47 8,897 60,196 64,182 67,644 70,644 70,930 All 0,74 3,946 4,41 3,73 4,278,84 9,320 62,148 64,267 67,343 70,190 72,291 73,008 Section K 4 Economic costs of ESRD 2009 USRDS Annual Data Report Model 1: As-treated actuarial model, the standard USRDS economic model in which all costs are attributed to the patient s modality at the time the costs are incurred. In the case of a modality change, the costs incurred after the change are attributed to the new modality. See Appendix A (Volume Two) for further details. Age is calculated as of January 1 of each calendar year. Vol 3 esrd pg 739

10 Table K.7 K.7 Per person per year costs ($): CAPD/CCPD with unknowns dropped (Model (model 1) 1) model, model, & ,310 1,977 3,361 0,003 44,499 41,138 46,17 3,227 6,266 71,704 77,046 71,113 69, ,838 44,066 47,84 46,60 34,3 47,063 41,277 40,213 39,34 4,036 0,037 60,718 70, ,161 40,17 40,334 37,911 34,464 34,834 32,740 36,347 43,201 44,88 3,301 60,309 2, ,302 38,089 37,03 38,24 37,67 38,112 40,200 42,38 41,836 38,926 48,321 48,701 47, ,00 38,079 3,889 37,292 38,211 38,107 38,412 39,779 41,226 43,238 4,903 48,989 49, ,47 40,03 40,92 40,442 39,430 41,238 41,463 42,0 42,77 43,274 47,317 0,024 0, ,780 41,41 41,1 40,309 40,448 41,874 43,464 4,883 46,073 46,739 47,430 0,669 0, ,079 4,20 44,342 4,10 43,669 4,384 46,471 48,091 48,004 49,90 1,07 3,262 2, ,623 4,462 4,708 46,796 44,939 47,673 48,67 49,77 49,030 0,81 2,648 3,46 2, ,49 46,70 49,07 48,31 46,611 47,373 1,470 1,97 2,686 3,679 4,429 7,326 6, ,961 47,832 49,002 48,761 47,664 49,8 1,099 0,07 1,060 1,739 4,840 6,42 6, ,261 46,698 4,604 44,949 4,81 4,287 48,026 1,138 2,24 2,71 6,828 8,613 8, ,177 42,73 47,709 4,8 44,646 47,200 4,0 46,70 1,38 48,366 2,412,963 7, ,470 41,671 41,18 40,79 37,361 38,784 39,298 42,071 4,893 46,901 4,792 7,687 6, ,686 39,942 39,619 39,74 39,430 40,43 41,480 42,722 42,98 44,411 47,29 0,61 0, ,671 44,497 44,018 44,329 43,218 4,310 46,214 48,06 48,047 49,342 0,494 2,382 2, ,004 47,069 49,220 48,7 47,016 48,04 1,276 0,821 2,20 2,486 4,49 7,046 6, ,48 47,489 47,36 47,196 47,100 47,97 49,738 0,36 0,944 2,126,336 6,848 7,7 Male 40,82 43,012 43,277 43,438 42,63 43,832 4,363 46,817 47,093 48,709 1,39 3,290 4,02 Female 42,770 4,21 4,364 4,261 44,081 4,913 47,289 48,182 49,013 49,84 1,260 4,107 2,834 White 41,779 43,876 44,728 44,42 43,23 44,70 46,264 47,378 47,71 49,446 1,601 4,088 3,419 African American 42,4 4,29 44,346 4,009 43,78 4,808 47,480 48,9 49,884 49,908 2,783 4,761,14 Native American 42,60 42,630 40,971 42,71 42,02 42,326 4,110 4,296 48,291 47,984 49,78 1,36 1,948 Asian 34,87 38,208 38,49 39,363 39,08 41,49 41,49 41,944 41,777 42,002 42,074 44,038 4,947 Other/unknown 38,98 38,469 38,690 39,87 37,642 44,778 40,928 44,342 44,989 43,743 43,128 0,039 0,98 Hispanic 41,72 42,669 42,034 42,109 41,88 43,863 4,399 4,79 48,349 47,849 0,374 0,71 Non-Hispanic 42,121 42,931 43,64 43,013 44,911 46,616 47,741 48,406 49,283 1,826 4,178 3,832 Diabetes 48,200 1,426 1,639 1,317 49,603 1,737 3,326 4,39 4,330 6,61 8,613 61,376 60,770 Hypertension 40,219 41,772 43,012 42,182 41,707 42,642 44,714 44,877 46,010 46,224 48,640 0,681 0,412 Glomerulonephritis 36,32 38,064 37,919 38, 38,364 38,836 39,984 41,36 42,77 42,766 4,134 47,878 46,290 Other cause 39,468 41,932 40,876 41,808 40,246 42,701 43,623 4,01 4,876 46,881 49,073 1,12 2,11 Unknown cause 38,9 39,218 39,140 39,883 40,710 41,19 41,369 43,793 41,821 44,427 46,627 47,20 0,407 All 41,778 44,079 44,29 44,336 43,37 44,870 46,318 47,489 48,039 49,138 1,329 3,686 3,446 pg 740 Model 1: As-treated actuarial model, the standard USRDS economic model in which all costs are attributed to the patient s modality at the time the costs are incurred. In the case of a modality change, the costs incurred after the change are attributed to the new modality. See Appendix A (Volume Two) for further details. Age is calculated as of January 1 of each calendar year.

11 Table K.8 K.8 Per person per year costs ($): transplant with unknowns dropped (Model (model 1) 1) model, model, & ,78 32,223 30,081 30,029 31,849 26,799 26,63 33,49 38,20 36,007 0,83 44,9 44, ,438 17,379 16,472 16,70 13,66 12,899 16,230 16,64 20,67 19,729 2,211 28,74 38, ,674 1,00 16,623 1,33 13,234 13,210 14,323 17,204 21,496 27,02 34,43 29,82 33, ,246 16,999 16,243 16,32 16,672 16,126 19,38 20,212 23,17 26,49 27,986 31,027 27, ,99 18,211 18,283 17,764 17,386 17,28 19,416 20,493 20,901 23,006 2,219 27,028 2, ,910 17,722 17,32 16,7 16,02 17,280 18,82 20,06 20,349 22,66 23,807 23,408 23, ,23 18,812 18,974 17,31 16,664 17,398 19,29 20,28 20,376 22,633 23,888 23,718 23, ,846 20,284 20,639 19,387 17,843 19,18 20,93 21,606 21,790 23,638 24,322 24,626 24, ,33 20,214 20,91 19,664 18,921 20,16 21,03 21,864 24,334 24,382 2,872 26,107 2, ,66 19,629 20,337 20,93 19,883 21,263 22,42 24,407 24,666 26,339 27,178 26,393 2, ,06 18,030 19,202 19,727 19,04 21,032 24,106 24,07 24,744 2,393 26,843 2,72 2, ,333 16,024 18,236 1,276 12,330 18,729 20,400 18,960 20,624 23,92 26,22 24,238 22, ,42 6,271 12,371 9,880 7,826 17,349 18,003 18,311 14,426 32,720 21,694 26,08 22, ,193 17,6 17,437 17,08 1,996 1,378 17,93 19,747 23,714 26,98 31,441 31,802 32, ,093 18,06 18,020 17,073 16,666 17,129 18,962 20,146 20,437 22,4 24,27 24,06 23, ,368 19,908 20,12 18,928 17,803 19,321 20,9 21,36 22,028 23,67 24,473 24,842 24, ,403 19,200 20,096 20,42 19,60 21,42 22,83 24,08 24,644 2,917 27,01 26,227 2, ,408 17,206 17,883 19,279 19,444 18,68 24,829 24,601 24,180 2,689 26,622 2,003 24,08 Male 18,6 18,10 18,66 18,014 17,301 18,298 20,228 20,917 21,879 23,629 24,896 24,867 24,190 Female 19,007 19,4 19,812 18,733 17,908 19,141 20,433 22,071 22,270 24,172 2,432 2,324 2,143 White 17,762 17,964 18,011 17,228 16,430 17,430 18,978 20,08 20,74 22,609 23,684 23,99 23,219 African American 22,927 22,961 23,403 22,31 21,644 23,203 2,193 26,286 27,004 28,180 30,097 29,994 29,339 Native American 18,344 18,623 19,381 17,884 18,916 18,377 19,924 20,08 21,306 23,861 2,88 2,704 24,417 Asian 14,847 1,484 16,603 16,013 1,070 1,477 17,966 18,17 17,964 20,439 21,471 21,813 21,289 Other/unknown 1,729 11,0 18,68 18,11 13,900 2,89 1,383 19,372 34,809 46,661 3,26 33,328 27,081 Hispanic 19,447 19,899 19,0 18,197 18,749 20,428 21,190 21,76 23,827 2,207 2,76 24,670 Non-Hispanic 20,283 20,172 19,166 18,281 19,480 21,124 22,221 22,800 24,332 2,16 2,384 2,012 Diabetes 2,18 2,748 2,971 24,388 23,004 2,20 27,143 29,077 29,48 31,37 32,742 31,969 31,230 Hypertension 19,3 19,221 19,474 18,487 18,102 18,9 21,662 22,33 22,8 24,293 2,467 24,912 24,624 Glomerulonephritis 1,41 1,660 16,111 1,299 14,802 1,424 16,499 17,270 17,906 19,666 20,43 20,816 20,224 Other cause 16,049 16,414 1,946 1,907 1,042 1,738 17,032 17,780 18,909 20,476 22,004 22,419 22,233 Unknown cause 13,980 14,170 1,464 14,883 14,783 1,46 16,44 17,19 16,16 19,311 21,021 21,733 20,02 All 18,73 18,923 19,11 18,301 17,4 18,637 20,310 21,38 22,038 23,848 2,113 2,01 24,72 Section K 4 Economic costs of ESRD 2009 USRDS Annual Data Report Model 1: As-treated actuarial model, the standard USRDS economic model in which all costs are attributed to the patient s modality at the time the costs are incurred. In the case of a modality change, the costs incurred after the change are attributed to the new modality. See Appendix A (Volume Two) for further details. Age is calculated as of January 1 of each calendar year. Vol 3 esrd pg 741

12 Table K.9 K.9 Per person per year costs ($): dialysis (Model (model 2) 2) & ,830 4,047 2,90 43,787 47,70 38,049 48,72,638 3,18 82,613 83,460 64,146 67, ,116 4,320 49,729 4,643 38,011 4,969 4,346 48,463 43,61 4,164 46,79 69,778 62, ,90 37,784 37,72 37,140 36,32 38,296 36,441 42,30 4,847 44,966,371 9,128 9, ,86 38,647 38,32 40,739 37,26 41,109 43,764 46,717 47,140 47,42 3,187 8,39 6, ,071 42,446 41,694 41,323 42,64 43,212 4,12 47,499 49,616 2,631 4,97 8,60 60, ,347 44,810 4,971 44,871 4,833 46,834 49,99 1,797 2,80,91 9,00 61,381 62, ,68 46,210 46,0 4,930 47,008 48,464 1,718 4,842 6,277 60,09 62,904 64,17 64, ,197 49,442 0,442 49,7 0,344 1,698,282 8,090 9,692 62,981 6,229 66,464 66, ,282 1,161 2,041 2,144 2,434 3,882 8,003 61,67 62,969 67,071 68,861 69,12 69, ,13 4,917 6,24,668,404 6,91 60,404 64,482 66,397 70,018 72,746 73,03 73, ,606 6,087 7,327 6,16 6,439 8,071 62,282 6,470 66,767 70,762 73,820 74,948 76, ,0 6,897 8,728 7,11 7,002 7,79 62,342 6,64 66,618 70,106 74,248 7,438 76, ,789 7,479 8,727 7,486 7,11 8,016 62,098 6,039 66,62 69,927 74,227 7,432 76, ,904 40,46 40,379 40,94 37,813 40,761 42,7 46,78 46,961 0,122,36 9,946 8, ,823 44,781 4,27 44,07 4,474 46,446 49,331 2,070 3,327 6,477 9,809 62,180 62, ,334 49,324 0,140 49,628 0,33 1,821,467 8,23 60,03 63,721 6,842 66,847 67, ,843,244 6,668 6,010,83 7,370 61,349 64,882 66,604 70,191 73,137 74,011 74, ,386 6,914 8,112 7,071 6,866 7,93 62,280 6,46 66,670 70,618 74,18 7,414 76,338 Male 46,311 49,370 0,369 49,926 0,332 1,09,074 8,276 9,822 63,416 66,603 67,719 68,139 Female 1,076 4,16,306 4,22 4,80 6,43 60,87 63,910 6,34 69,068 71,49 72,881 73,472 White 49,42 2,73 3,840 3,23 3,238 4,98 8,421 61,4 63,101 66,34 69,481 70,0 71,068 African American 48,077 1,129 1,973 1,319 2,128 3,40 7,14 60,884 62,41 66,93 69,46 70,968 71,394 Native American 4,029 47,672 47,62 47,22 48,376 48,70 1,172,430,703 8,279 8,949 9,702 60,077 Asian 41,993 44,89 46,308 4,929 47,076 48,849 1,476,073 4,826 7,84 9,84 60,23 60,920 Other/unknown 1,41 3,21 1,036 2,071 2,21,672 6,64 8,779 8,176 62,30 64,91 64,384 66,486 Hispanic 1,104 1,90 1,897 1,674 2,937 6,439 60,037 61,82 64,724 67,276 68,81 69,622 Non-Hispanic 1,708 2,717 2,041 2,443 3,892 7,920 61,16 62,74 66,323 69,20 70,371 70,762 Diabetes 4,403 8,093 9,003 8,041 7,646 9,00 63,226 66,289 67,916 71,693 74,62 7,998 76,287 Hypertension 47,181 49,681 0,600 49,881 0,603 1,94,310 8,486 9,86 63,14 6,876 67,064 67,687 Glomerulonephritis 42,480 44,433 44,747 44,398 4,103 46,098 48,941 1,678 3,037,824 7,997 8,96 9,140 Other cause 4,71 48,9 0,124 49,387 0,169 1,91,633 9,167 60,744 63,999 66,77 67,18 67,920 Unknown cause 4,03 48,71 48,9 48,837 49,077 0,91 2,873 7,011,847 62,924 66,191 67,292 67,902 All 48,644 1,711 2,768 2,11 2,16 3,870 7,704 60,941 62,422 66,061 68,901 70,102 70,81 pg 742 Model 2: Categorical calendar year model. Patients are classified into four mutually exclusive modality groups, based on calendar year. If a patient receives a transplant during a calendar year, he or she is placed into the transplant event modality & costs are aggregated for the entire time that the patient is alive, ESRD, & entitled during the calendar year. Other modalities (dialysis, functioning graft, graft failure) are defined in a similar fashion. See Appendix A (Volume Two) for further details. Age is calculated as of January 1 of each calendar year.

13 Table K.10 Per person per year costs ($): with a transplant event within the year (model 2) & & Per person per year costs ($): with a transplant event within the year (Model 2) , ,787 94, ,766 94,21 89,94 97,88 101, , , , , , ,2 99, ,070 91,779 89,83 92,828 82,744 78,329 89,027 82, , , , ,016 83,13 93,91 83,624 77,868 77,430 88,976 81,722 9,246 99,766 97, , , ,362 84,970 82,431 88,683 79,669 79,34 87,982 91,473 90,778 99, ,120 98, , ,790 87,221 88,81 86,608 8,736 83,993 89,974 92,19 92,80 92,167 99,03 101,01 10, ,046 93,98 90,401 87,126 89,474 91,611 92,86 93,99 94, , , , , ,187 91,613 92,997 87,681 89,178 92,717 93,429 96,624 94,796 98,84 102,8 10,04 103, ,78 93,421 9,06 91,87 91,106 9,337 94,44 97,123 97,01 103, , , , ,892 93,470 94,103 94,11 93,3 97,309 98,4 99, ,6 100,096 10, ,96 110, ,668 97, , ,629 98,01 98, ,78 103, , , , ,47 113, ,699 91, ,21 103, , , , ,30 104, , ,83 114, , ,276 71,019 88,063 77,466 71, , ,8 74,142 91, ,84 124,93 87, , , , , ,630 72, ,812 19, ,877 90,19 90,290 89,400 81,880 81,266 88,399 88,287 94,443 99, , , , ,698 91,242 90,39 86,843 88,291 89,408 92,40 93,917 94,28 97,6 102, , , ,847 92,94 94,482 91,281 91,192 9,06 94,738 97,844 97, , , , , ,382 96,708 10, ,11 99,439 99,640 10,11 103,86 102, ,69 110, ,13 111, ,966 74,709 11, ,386 91, , ,20 11, , , , ,163 10,978 Male 92,102 90,693 92,689 89,614 89,876 92,08 9,219 96,02 96,427 99, , ,22 10,077 Female 92,764 94,73 94,190 90,9 90,728 94,11 94,437 98,222 97, , , ,37 108,440 White 92,62 92,648 94,114 90,627 88,904 91,474 93,481 96,31 9, , ,871 10,71 10,404 African American 93,320 91,646 92,634 90,149 93,881 97,189 99,082 99, , , , , ,64 Native American 88,974 88,208 90,144 79,037 8,834 8,149 82,604 87,71 93,620 88,04 102,44 99, ,792 Asian 81,83 91,191 86,232 86,417 86,48 86,08 89,080 92,22 88,761 92,27 97,72 98,21 98,129 Other/unknown 84,18 12,048 83,231 70,490 67,31 94,23 76,66 72,040 96,380 9,133 91, ,71 106,172 Hispanic 90,100 92,837 86,763 86,96 86,894 89,33 90,276 91,419 9,4 96,67 101,44 102,866 Non-Hispanic 92,462 93,18 90,446 90,701 93,836 9,82 98,10 97, ,36 10, , ,790 Diabetes 99,807 99, ,82 96,082 94,83 102, ,726 10,23 106, , , , ,482 Hypertension 90,7 88,482 91,763 87,826 90,81 91,797 94,71 96,210 94,417 97,346 99, ,26 100,922 Glomerulonephritis 87,678 88,216 88,927 86,119 86,362 86,47 89,112 90,88 90,688 94,81 96, ,46 100,324 Other cause 90,402 92,92 91,032 89,76 88,467 89,464 92,06 93,269 9,022 99,34 103,261 10, ,0 Unknown cause 102,470 93,812 97,20 93,732 92,229 96,226 92,274 98,020 89,32 102,32 109, ,01 11,108 All 92,37 92,264 93,294 90,18 90,221 92,928 94,900 96,923 96, , , ,80 106,373 Section K 4 Economic costs of ESRD 2009 USRDS Annual Data Report Model 2: Categorical calendar year model. Patients are classified into four mutually exclusive modality groups, based on calendar year. If a patient receives a transplant during a calendar year, he or she is placed into the transplant event modality & costs are aggregated for the entire time that the patient is alive, ESRD, & entitled during the calendar year. Other modalities (dialysis, functioning graft, graft failure) are defined in a similar fashion. See Appendix A (Volume Two) for further details. Age is calculated as of January 1 of each calendar year. Vol 3 esrd pg 743

14 Table K.11 K.11 Per person per year costs ($): with a functioning graft (Model (model 2) 2) & ,223 14,61 16,022 13,689 10,48 18,649 13,199 1,23 16,726 21,04 26,21 23,0 16, ,637 7,796 7,417 10,001 8,068 7,32 8,70 10,798 13,023 12,932 12,383 18,417 17, ,943 7,368 8,636 7,79 6,873 7,43 7,97 8,841 11,969 14,43 20,642 14,281 16, ,700 7,837 8,04 7,028 7,726 8,74 10,688 9,617 13,03 14,760 13,00 16,087 14, ,962 8,043 8,707 8,490 8,74 8,234 9,83 10,74 11,722 12,94 14,032 14,2 13, ,26 9,89 9,90 9,631 9,3 9,832 11,07 12,037 12,23 13,411 14,27 14,248 13, ,278 11,028 11,10 10,782 10,200 10,907 12,186 13,174 13,87 1,042 1,881 1,03 14, ,189 12,63 13,168 12,476 11,69 12,999 13,899 14,642 1,3 16,204 16,967 16,481 16, ,27 12,960 14,300 13,746 13,337 14,696 1,700 16,049 18,313 18,139 19,060 18,878 18, ,790 13,974 14,023 14,293 14,472 1,488 16,718 18,121 18,700 20,360 20,43 19,349 19, ,6 13,870 14,64 1,639 1,964 16,428 18,963 19,24 20,362 21,328 21,900 20,944 21, ,484 13,346 17,248 13,460 11,696 1,394 16,97 17,042 18,790 19,391 22,9 21,33 20, ,432 6,28 11,013 8,79 7,14 13,188 17,224 1,689 14,000 29,230 18,2 23,43 17, ,240 8,134 8,667 8,224 7,67 8,688 9,662 9,930 13,297 14,940 16,203 16,74 1, ,189 9,793 10,07 9,687 9,391 9,772 11,110 12,080 12,733 13,773 14,888 14,60 14, ,707 12,29 12,788 12,309 11,748 12,886 13,910 14,641 1,819 16,401 17,209 16,844 16, ,777 13,792 14,289 14,643 14,761 1,884 17,314 18,386 19,217 20,609 20,844 19,930 19, ,616 1,690 13,913 16,00 17,186 1,607 20,089 19,860 20,614 21,897 22,799 21,30 21,446 Male 10,398 11,060 11,327 11,247 10,870 11,814 13,219 14,011 1,293 16,237 17,036 16,69 16,318 Female 11,062 11,462 12,203 11,707 11,608 12,413 13,748 14,948 1,899 16,990 18,028 17,620 17,636 White 10,2 11,04 11,367 11,121 10,947 11,779 13,122 13,96 1,233 16,283 17,121 16,747 16,78 African American 11,800 12,94 13,320 13,072 12,416 13,61 1,03 16,447 17,402 18,14 19,301 18,920 18,479 Native American 10,660 10,20 12,070 11,769 11,884 12,338 14,643 13,714 14,026 16,640 17,047 16,66 16,422 Asian 6,678 6,842 8,261 8,132 8,189 8,497 10,049 11,26 11,403 12,33 13,128 13,202 13,401 Other/unknown 9,63 4,182 10,899 4,301 4,192 10,697 8,931 12,47 10,837 17,19 19,49 17,483 1,747 Hispanic 11,21 11,029 10,934 10,719 11,329 12,93 13,713 14,680 1,770 17,062 17,316 16,326 Non-Hispanic 11,34 12,070 11,728 11,440 12,448 13,71 14,777 1,926 16,821 17,673 17,23 17,167 Diabetes 17,048 17,823 18,24 17,229 16,36 17,87 19,723 21,141 22,034 23,096 24,106 23,462 22,91 Hypertension 10,010 10,392 10,97 10,844 10,644 11,11 13,43 14,214 1,477 16,197 17,03 16,126 16,37 Glomerulonephritis 7,768 8,282 8,879 8,643 8,3 9,336 10,043 10,899 11,936 12,911 13,774 13,433 13,366 Other cause 8,691 9,006 9,126 9,14 9,423 9,927 11,08 11,774 13,21 14,219 1,019 1,13 1,203 Unknown cause 8,368 9,383 9,660 9,04 9,791 9,780 11,296 11,902 11,464 13,108 13,967 13,838 13,24 All 10,661 11,218 11,674 11,430 11,16 12,0 13,432 14,388 1,36 16,40 17,43 17,067 16,844 pg 744 Model 2: Categorical calendar year model. Patients are classified into four mutually exclusive modality groups, based on calendar year. If a patient receives a transplant during a calendar year, he or she is placed into the transplant event modality & costs are aggregated for the entire time that the patient is alive, ESRD, & entitled during the calendar year. Other modalities (dialysis, functioning graft, graft failure) are defined in a similar fashion. See Appendix A (Volume Two) for further details. Age is calculated as of January 1 of each calendar year.

15 Table K.12 K.12 Per person per year costs ($): with a graft failure within the year (Model (model 2) 2) & , ,176 82, ,48 71, ,07 211,3 16, ,902 6, ,306 16,709 97,786 7,03 86,674 80,978 28,489 1,386 26,708 26, ,703 89,69 8, ,093 42,74 69,17 42,6 3,874 39,173,23 3,042 60,84 3,361 68, ,02 11, ,997 2,27 7,668 46,2 2,82 63,294 3,179 63,71 64,731 69,671 77,90 71,442 67, ,117 7,34 48,67 0,700 1,034 4,194 4,16 60,820 7,171 63,102 73,68 73,11 82, ,116 3,966 6,422,14 6,862,048 8,808 67,823 64,303 69,670 73,02 78,839 73, ,172 6,30 60,99 7,970 60,243 8,636 6,778 64,964 67,66 71,111 72,39 72,760 80, ,000 63,09 63,12 64,64 6,31 66,640 70,288 76,291 69,604 76,721 81,997 83,2 79, ,282 70,016 71,930 72,412 73,31 71,970 77,639 72,842 90,018 89,662 88,029 88,7 92, ,80 69,828 70,941 80,928 73,886 60,633 77,780 87,846 97,103 90,037 86,887 98,976 8, ,31 98,748 80,70 6,423 61,87 6,199 93,300 84,11 90,08 9,317 97,670 96, , ,440 38,299 60, , ,006 70,76 92,203 49, , , , ,232 34, ,781 4,942 63,243 49,431 4,102 9,228 3,91 61,114 6,890 66,362 78,6 8,928 86, ,441,42 4,86,669,664,474 8,18 6,706 63,331 66,399 74,119 74,07 74, ,0 61,747 6,601 62,13 6,83 6,77 71,784 72,087 73,390 79,349 79,300 82,348 84, ,643 77,39 7,226 74,7 69,172 61,842 84,189 87,60 94,910 90,464 91,376 97,034 92, ,03 84,110 69,396,976 70,847 67,723 93,783 84,66 88, ,698 9,92 108,36 104,86 Male 1,939,77 6,11 7,001 60,706 8,446 66,182 66,9 68,92 72,21 7,26 78,64 81,326 Female 6,838 63,899 6,84 62,461 60,360 63,670 66,624 74,966 76,006 81,191 84,838 87,109 84,917 White,487 9,2 9,398 9,782 60,83 9,174 66,492 71,238 71,740 74,984 79,617 82,49 83,923 African American 1,921 8,712 62,78 7,438 60,21 63,40 6,966 70,982 72,900 78,666 78,929 82,93 82,933 Native American 4,131 48,817 60,78 2,341 43,348 6,804 60,083 71,24 74,79 74,326 79,242 89,142 74,269 Asian 36,094 4,03 3,46 68,618 63,90 8,497 70,992 49,064 7,144 61,689 73,784 70,26 66,88 Other/unknown 113,333 24, ,862 12,63 73,76 73,070 40,960 42,04 120,72 97,73 72,748 Hispanic 6,302 7,473 7,280 61,689 6,614 64,839 70,26 73,19 70,323 78,78 81,024 86,309 Non-Hispanic 8,893 60,369 9,177 60,169 60,809 66,48 70,18 71,383 76,794 79,62 82,6 82,720 Diabetes 68,473 69,893 74,940 71,64 76,367 74,894 80,916 86,19 88,707 94,446 93,761 96,221 98,264 Hypertension 48,6,770 61,028 7,272 9,31 7,68 62,0 70,291 72,712 73,206 73,276 80,476 7,76 Glomerulonephritis 0,701 3,03 2,210 3,103 3,328 2,724 9,04 60,91 60,632 66,838 70,01 72,143 7,094 Other cause 1,307 61,10 9,332,29 7,087 60,913 6,127 66,677 68,062 70,38 80,889 79,713 79,723 Unknown cause 4,464 2,974 0,488 80,078 9,009 6,810 67,609 69,173 67,466 69,807 74, , ,211 All 3,863 8,97 60,31 9,187 60,6 60,60 66,362 70,48 71,707 7,87 79,316 82,191 82,76 Section K 4 Economic costs of ESRD 2009 USRDS Annual Data Report Model 2: Categorical calendar year model. Patients are classified into four mutually exclusive modality groups, based on calendar year. If a patient receives a transplant during a calendar year, he or she is placed into the transplant event modality & costs are aggregated for the entire time that the patient is alive, ESRD, & entitled during the calendar year. Other modalities (dialysis, functioning graft, graft failure) are defined in a similar fashion. See Appendix A (Volume Two) for further details. Age is calculated as of January 1 of each calendar year. Vol 3 esrd pg 74